Vyarna Frequently Asked Questions

Preorder Vyarna
This page answers common questions about breastmilk biology, how Vyarna is produced, how safety is verified, and how the product can be used.

Understanding Breastmilk

Breastmilk is unique because it is a biologically active fluid.
It provides essential nutrients—fats, proteins, carbohydrates, vitamins, and minerals—along with bioactive components that guide the development of the immune, digestive, and brain systems.
These elements interact with the infant’s body to support early-life biological processes.
Some key components of breastmilk include:
Immune cells and antibodies Breastmilk contains immune cells (cells that help protect against infection) and antibodies (proteins that help identify and neutralize harmful bacteria and viruses). One important antibody, secretory IgA (sIgA), helps protect the lining of a baby’s mouth and digestive tract by forming a protective barrier against pathogens.
Protective proteins Breastmilk contains protective proteins, including lactoferrin (a protein that binds to iron and makes it harder for bacteria to grow) and lysozyme (an enzyme that speeds up reactions and breaks down bacterial cell walls). These protective proteins help defend against microbes and support a healthy balance of microorganisms.
Human Milk Oligosaccharides (HMOs) Human Milk Oligosaccharides (HMOs) are specialized carbohydrates unique to human milk. HMOs primarily serve as food for beneficial gut bacteria, helping shape the infant gut microbiome and supporting digestive and immune development.
Signaling molecules Breastmilk contains hormones, growth factors, and cytokines—molecules that regulate immune maturation, metabolism, and tissue development during infancy.
The milk microbiome Breastmilk contains beneficial microbes that help establish the infant’s gut microbiome.
Breastmilk composition changes over time. Early milk (colostrum) is rich in immune-supporting components, while later milk adapts to the baby’s evolving needs.
Together, these elements work as an integrated system that supports development during the earliest stages of life.
Health organizations such as the World Health Organization (WHO) recommend initiating breastfeeding within the first hour after birth when possible.
The first months after birth represent a period of rapid biological development.
During this time: • The immune system is maturing • The digestive system is adapting • The gut microbiome is forming • The brain is developing rapidly
Breastmilk delivers antibodies, immune proteins, HMOs, and signaling molecules for system development.
Colostrum, the first milk produced after birth, contains particularly high concentrations of antibodies and immune-supporting compounds that help protect the newborn during the earliest days of life.
As the baby grows, breastmilk naturally adapts to support changing needs.
This adaptability makes breastmilk a biologically active system that supports early development.

What Vyarna Is

Vyarna is a freeze-dried human breastmilk product made from verified, laboratory-tested breastmilk.
Through freeze-drying, liquid breastmilk is converted into a shelf-stable, additive- and preservative-free powder. Removing water allows the milk to be stored safely and used in situations where fresh milk may not be available or practical.
Vyarna is designed to complement a baby’s existing feeding routine, not replace it. The powder can be incorporated alongside breastfeeding, pumped milk, formula, or age-appropriate foods, depending on the child’s feeding stage.
For infants, Vyarna may be mixed into pumped milk or formula. For older babies or toddlers, it can be added to soft foods or liquids. Some adults interested in human milk biology may also incorporate it into foods or smoothies.
The product is developed around the concept of bio-information diversity — the presence of multiple biological components naturally found in human milk, including immune molecules, proteins, and microbial signals that interact with the developing body.
No.
Vyarna is not a replacement for direct breastfeeding or infant formula.
It was created as a complementary product that allows preserved human breastmilk to be included alongside existing feeding practices.
The freeze-drying process does not modify the biological components of milk. Instead, it removes water to preserve the naturally occurring components of breastmilk.
Vyarna is developed around the concept of supporting bio-information diversity, referring to the wide range of biological signals and components naturally present in human milk.
No.
The milk used in Vyarna does not come from traditional milk bank donation systems.
Instead, it is sourced from independent milk providers who voluntarily choose to participate in Vyarna’s sourcing program.
Milk providers are compensated for their contributions, and every batch of milk is laboratory-tested before entering production.
The sourcing process is designed to combine traceability, safety verification, and recognition of the mothers who provide milk.
Freeze-drying (scientifically known as lyophilization) is a preservation method that converts liquid breastmilk into a shelf-stable powder.
The process removes most of the water from the milk at very low temperatures. By removing moisture while keeping the temperature low, freeze-drying helps preserve many of the natural components present in breastmilk.
How the process works:
Freezing The milk is first frozen at very low temperatures.
Sublimation In a controlled vacuum, frozen water is removed as vapor, bypassing the liquid phase.
Powder form The result is a fine powder containing many proteins, fats, carbohydrates, and other natural milk components.
Why freeze-drying is used Unlike pasteurization, which uses heat, freeze-drying preserves milk by water removal at low temperatures. Because the moisture has been removed, freeze-dried breastmilk can be stored for longer periods without the need for additives or preservatives.
At Vyarna, freeze-drying allows human breastmilk to be preserved in a stable powdered form that can later be incorporated into different feeding routines.

Sourcing & Ethics

The breastmilk used in Vyarna comes from breastfeeding mothers who choose to participate as milk providers.
These women voluntarily contribute milk through a documented sourcing process. Their milk is collected, tracked, and then sent for laboratory testing before entering production.
Every batch is traceable throughout the testing and freeze-drying process. Only milk that passes safety testing is used.
Vyarna’s sourcing model is designed to recognize the contribution of the mothers who provide milk while ensuring that the material entering production is verified through laboratory testing.
Yes. Milk providers are compensated for their contribution.
Vyarna believes that when human milk is used to create value, the mothers who provide it should be recognized and fairly compensated.
In addition to direct compensation, the company has structured a portion of its equity to support providers and mission-driven initiatives connected to the sourcing of human milk.
Vyarna was designed with a structural commitment to ethical responsibility.
A portion of company equity is reserved to support milk providers and mission-driven initiatives connected to the sourcing and use of human milk.
The goal is to align the long-term success of the company with the mothers and communities that make the product possible.
Participation as a milk provider is voluntary.
Mothers who choose to participate do so independently and are compensated for the breastmilk they provide. All breastmilk entering production is documented, tracked, and tested before processing.
Vyarna’s sourcing framework focuses on transparency, traceability, and laboratory verification of the milk itself. The goal is to ensure that the process respects the contribution of the providers while maintaining clear safety standards for the material used in production.

Safety and Testing

Breastmilk is collected from verified providers and handled under controlled conditions using sterile containers to minimize contamination during collection and transport.
Before processing, samples are screened across four safety categories:
Viral screening Testing for specific viral contaminants that could pose safety risks.
Microbial analysis Screening for harmful bacterial contamination.
Drug residue detection Testing for the presence of pharmaceutical or illicit substances.
Adulteration testing Verification that the breastmilk has not been mixed with non-human milk or other substances.
Only breastmilk that meets laboratory criteria across all four categories proceeds to the next stage of processing.
After safety verification, the breastmilk is freeze-dried (lyophilized)—a dehydration process that removes water while preserving biological material without chemical additives. This process produces a stable powdered form that can be safely stored and handled during subsequent production steps.
Batch testing means that defined groups of breastmilk are tested together during production.
A batch refers to a specific quantity of breastmilk processed together during laboratory testing and freeze-drying.
Each batch must meet standards before continuing production.
Batch tracking is particularly important because Vyarna combines breastmilk from multiple verified providers into a single formulation.
Tracking by batch allows the production process to maintain traceability, quality control, and consistent safety verification throughout manufacturing.
Health status can change over time.
A provider who tests negative for a condition at one point may later be exposed to a virus, bacteria, medication, or other substance that could affect breastmilk composition.
For this reason, Vyarna’s safety model focuses primarily on testing the breastmilk itself before it enters production.
By verifying the biological material directly, safety validation is based on the material entering the production process rather than relying solely on historical provider screening. This approach prioritizes direct laboratory verification of the breastmilk being processed.

How to Use Vyarna

Vyarna comes in single-use packets containing freeze-dried, powdered human breastmilk.
To use, open a packet and mix the powder into a small amount of liquid or soft food. You can add Vyarna to: • pumped breastmilk • infant formula • soft foods • smoothies • small amounts of water offered by spoon or dropper
Stir or swirl the mixture gently until the powder dissolves.
Use room-temperature or lukewarm liquids for best results. Do not microwave or add to hot liquids, as high heat may affect its natural biological components.
Yes, Vyarna mixes well with prepared formula and may be used alongside formula feeding.
It is meant to complement, not replace, current feeding routines.
Yes, Vyarna is suitable as a breastfeeding supplement.
Some families choose to use it during transitional feeding phases, such as moving from breastfeeding to formula feeding, mixed feeding, or weaning.
Vyarna is designed to be easily incorporated into a child’s existing feeding routine.
Each packet contains 1 gram of freeze-dried human breast milk and can be mixed into a bottle, soft food, or other feeding medium.
Detailed usage guidance will be clearly indicated on the product label when Vyarna launches. Families should consult their pediatrician for guidance appropriate to their child.

Who Vyarna Is Intended For

Vyarna is primarily designed for infants during early development, particularly within the first 1,000 days of life, a period widely recognized as critical for growth and development.
Human breast milk has long been studied for its biological role in infant nutrition. Vyarna is developed and presented within this context of infant-related use.
Vyarna is 100% human breast milk.
The product is developed and positioned for infant-related use, and Vyarna does not make performance or medical claims.
That said, interest in human milk extends beyond infancy, particularly in scientific and research-driven communities. Adults who choose to engage with human milk do so for personal reasons and at their discretion.

Launch and Availability

Vyarna is preparing for commercial launch in the United States in 2026. Families interested in updates and early access can join the waitlist.

Access Vyarna Early

Preorders for the Vyarna Launch Box are now available in limited quantities.
Preorder Vyarna